Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Smith

Showing results (71-80 of 168) with videos related to

Pageof 17
Sort By:
Cancer|August 28, 2009
Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862): trial results and interleukin-6 analysis: a study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 ConsortiumDeborah Bradley, Dana Rathkopf, Rodney Dunn, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2015
A phase I open-label trial evaluating the cardiovascular safety of regorafenib in patients with advanced cancerRobin L Jones, Johanna C Bendell, David C Smith, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 7, 2004
The effect of leucodepletion on leucocyte activation, pulmonary inflammation and respiratory index in surgery for coronary revascularisation: a prospective randomised studyChristos Alexiou, Augustine A T Tang, Stuart V Sheppard, et al.
Investigational New Drugs|November 5, 2010
Phase II study of cilengitide (EMD 121974, NSC 707544) in patients with non-metastatic castration resistant prostate cancer, NCI-6735. A study by the DOD/PCF prostate cancer clinical trials consortiumAjjai Alva, Susan Slovin, Stephanie Daignault, et al.
ACS Nano|August 28, 2014
Raman spectroscopy of optical transitions and vibrational energies of ∼1 nm HgTe extreme nanowires within single walled carbon nanotubesJoseph H Spencer, John M Nesbitt, Harrison Trewhitt, et al.
Urology|July 13, 2004
Prospective quality-of-life assessment in patients receiving concurrent gemcitabine and radiotherapy as a bladder preservation strategyJoseph M Herman, David C Smith, James Montie, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2002
The use of preferences to measure the benefit of adjuvant radiation therapy for stage I seminomaJune L Chan, Mohammed U Kabeto, A Elizabeth Oldread, et al.
Investigational New Drugs|December 29, 2018
A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumorsDavid C Smith, Rashmi Chugh, Amita Patnaik, et al.
Cancer Chemotherapy and Pharmacology|July 6, 2016
Lack of pharmacokinetic drug-drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumorsLaura Q M Chow, David C Smith, Antoinette R Tan, et al.
Nature Communications|February 27, 2021
The contribution of water radiolysis to marine sedimentary lifeJustine F Sauvage, Ashton Flinders, Arthur J Spivack, et al.
Pageof 17

Showing results (71-80 of 168) with videos related to

Sort By:
Pageof 17
Cancer|August 28, 2009
Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862): trial results and interleukin-6 analysis: a study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 ConsortiumDeborah Bradley, Dana Rathkopf, Rodney Dunn, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2015
A phase I open-label trial evaluating the cardiovascular safety of regorafenib in patients with advanced cancerRobin L Jones, Johanna C Bendell, David C Smith, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 7, 2004
The effect of leucodepletion on leucocyte activation, pulmonary inflammation and respiratory index in surgery for coronary revascularisation: a prospective randomised studyChristos Alexiou, Augustine A T Tang, Stuart V Sheppard, et al.
Investigational New Drugs|November 5, 2010
Phase II study of cilengitide (EMD 121974, NSC 707544) in patients with non-metastatic castration resistant prostate cancer, NCI-6735. A study by the DOD/PCF prostate cancer clinical trials consortiumAjjai Alva, Susan Slovin, Stephanie Daignault, et al.
ACS Nano|August 28, 2014
Raman spectroscopy of optical transitions and vibrational energies of ∼1 nm HgTe extreme nanowires within single walled carbon nanotubesJoseph H Spencer, John M Nesbitt, Harrison Trewhitt, et al.
Urology|July 13, 2004
Prospective quality-of-life assessment in patients receiving concurrent gemcitabine and radiotherapy as a bladder preservation strategyJoseph M Herman, David C Smith, James Montie, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2002
The use of preferences to measure the benefit of adjuvant radiation therapy for stage I seminomaJune L Chan, Mohammed U Kabeto, A Elizabeth Oldread, et al.
Investigational New Drugs|December 29, 2018
A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumorsDavid C Smith, Rashmi Chugh, Amita Patnaik, et al.
Cancer Chemotherapy and Pharmacology|July 6, 2016
Lack of pharmacokinetic drug-drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumorsLaura Q M Chow, David C Smith, Antoinette R Tan, et al.
Nature Communications|February 27, 2021
The contribution of water radiolysis to marine sedimentary lifeJustine F Sauvage, Ashton Flinders, Arthur J Spivack, et al.
Pageof 17